Childbearing at an older age has been associated with a lower risk of endometrial cancer, but whether the association is independent of the number of births or other factors remains unclear. Individual-level data from 4 cohort and 13 case-control studies in the Epidemiology of Endometrial Cancer Consortium were pooled. A total of 8,671 cases of endometrial cancer and 16,562 controls were included in the analysis. After adjustment for known risk factors, endometrial cancer risk declined with increasing age at last birth (P trend < 0.0001). The pooled odds ratio per 5-year increase in age at last birth was 0.87 (95% confidence interval: 0.85, 0.90). Women who last gave birth at 40 years of age or older had a 44% decreased risk compared with women who had their last birth under the age of 25 years (95% confidence interval: 47, 66). The protective association was similar across the different age-at-diagnosis groups and for the 2 major tumor histologic subtypes (type I and type II). No effect modification was observed by body mass index, parity, or exogenous hormone use. In this large pooled analysis, late age at last birth was independently associated with a reduced risk of endometrial cancer, and the reduced risk persisted for many years. endometrial neoplasms; parity; reproductive history Abbreviations: BMI, body mass index; CI, confidence interval; E2C2, Epidemiology of Endometrial Cancer Consortium; OC, oral contraceptive; OR 5 , odds ratio per 5-year increase.
examine how age at last birth affects the risk of endometrial cancer and how this is influenced by other risk factors for the disease. The large number of cases and controls also allowed us to evaluate associations by tumor subtype.
MATERIALS AND METHODS

Participating studies
Seventeen studies (4 cohort and 13 case-control) in the Epidemiology of Endometrial Cancer Consortium (E2C2) that collected information on age at last birth or age at last pregnancy were included in the pooled analysis (3, (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . The E2C2 is an international consortium established to pool resources and data from many endometrial cancer studies in an effort to identify genetic and environmental risk factors for endometrial cancer (28) . Cohort studies were analyzed as nested case-control studies, with up to 4 controls randomly selected (among women with an intact uterus and without endometrial cancer before the diagnosis of the index case) for each case based on exact year of birth, date of cohort entry (±6 months), and other criteria as appropriate for each individual study (e.g., race/ethnicity, study area, etc.). The characteristics of the individual studies and the matching variables for both the cohort and case-control studies are shown in Table 1 . For most studies, the large majority of participants were non-Hispanic whites. Two studies, the Hawaii Endometrial Cancer Study and the Shanghai Endometrial Cancer Study, included mainly or exclusively nonwhite populations. The number of endometrial cancer cases in each study ranged from 232 to 1,396. Informed consent was obtained from all study participants as part of the original studies and in accordance with each study's institutional review board.
Data collection
Data from individual studies were received at the E2C2 data coordinating center at Memorial Sloan-Kettering Cancer Center with personal identifiers removed. Each data set was checked for inconsistencies and completeness. Queries were sent to the investigators to resolve inconsistencies and any other data issues. Data on age at last birth (or full-term pregnancy, i.e., pregnancy lasting more than 6 months) were provided by 15 of the 17 studies; 2 studies (the California Teachers Study and the Patient Epidemiologic Data System Study) only provided data on age at last pregnancy. These variables were considered the same in the main analysis, but results are also given excluding these 2 studies. Each study also provided information regarding tumor characteristics, demographic variables, and known/ potential risk factors and covariates (Table 2 ). These variables were defined and uniformly recoded in accordance with the E2C2 data dictionary (available upon request).
Tumor histology
Only incident cases of endometrial cancer ( primary site codes C54 and C55.9) were included in this analysis. 
Exclusion criteria
Women who were nulliparous (2,168 cases and 2,561 controls) and women for whom we were missing information on parity (83 cases and 125 controls) or age at last birth, full-term pregnancy, or last pregnancy (248 cases and 550 controls) were excluded from the analyses. Women with missing body mass index (BMI, measured as weight in kilograms divided by height in meters squared) values (185 cases and 280 controls) were also excluded from the analysis because BMI is an important potential confounder. After these exclusions, 8 , OC use (never or ever), menopausal hormone use (never or ever), menopausal estrogen use (never or ever), diabetes (no or yes), and smoking status (never, past, or current). Categories for missing data were created for age at menarche, OC use, menopausal hormone use, diabetes, and smoking status. The association between endometrial cancer and age at last birth in each study was assessed by calculating odds ratios and 95% confidence intervals using logistic regression stratified by age × race/ethnicity, and when data were available, they were adjusted for BMI, age at menarche, parity, OC use, menopausal hormone use, diabetes, and smoking status. We estimated the combined odds ratio and 95% confidence interval for age at last birth from these individual study results using a random-effects model and tested for the statistical significance of betweenstudy heterogeneity using the Q test statistics (33, 34) . No asymmetry was observed in the funnel plot of the effect estimates from individual studies (data not shown).
We also analyzed the complete individual data using a pooled analysis stratified by study × age × race/ethnicity and adjusted for BMI, age at menarche, parity, OC use, menopausal hormone use, diabetes, and smoking status. Tests for trend were performed by entering the ordinal values representing categories of age at last birth as a continuous variable in the models. We investigated effect modification of the association between age at last birth and endometrial cancer risk by BMI, parity, OC use, and menopausal estrogen use. Interaction analysis with menopausal estrogen use was limited to postmenopausal women in the 13 studies with information on both menopausal status and menopausal estrogen use. Women who had ever used estrogen alone were compared with women who had never used any type of menopausal hormone. Tests of interaction were assessed using log-likelihood test statistics comparing models with and without the interaction term. We investigated how time since last birth affected the association of age at last birth with endometrial cancer by estimating the effect of age at last birth in increasing age at diagnosis categories. We also examined the effect of age at last birth for the 2 major tumor histologic classifications (type I and type II) using a polytomous logistic regression model and tested the null hypothesis that there was no difference in the pooled odds ratios between type I and type II tumors. All statistical tests (P values quoted) were 2-sided. Statistical analyses were performed using Stata, version 11.0 (StataCorp LP, College Station, Texas) and SAS, version 9.2 (SAS Institute, Inc., Cary, North Carolina).
RESULTS
Characteristics of the 8,671 cases and 16,562 controls included in the pooled analysis are shown in Table 2 . The majority of women were non-Hispanic white (80.1% of cases and 84.9% of controls) and postmenopausal (66.5% of cases and 63.6% of controls). On average, cases had higher BMIs than did controls. Cases were more likely to have had an earlier age at menarche, had fewer births, have used menopausal hormones, and be diabetic. Cases were less likely to have used OCs or to have ever smoked.
A forest plot of the study-specific risk estimates for endometrial cancer per 5-year increase in age at last birth is Figure 1 . The risk of endometrial cancer associated with a 5-year increase in age at last birth by study. The numbers of cases and controls shown in each study were after all exclusions had been applied. Odds ratios were stratified by age and race/ethnicity and, when possible, were adjusted for parity, age at menarche, body mass index, oral contraceptive use, menopausal hormone use, smoking, and diabetes. The combined odds ratio per 5-year increase of 0.88 (95% confidence interval: 0.85, 0.91) was calculated using a random-effects model with a P for heterogeneity of 0. 12 
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shown in Figure 1 . All but one study (US Endometrial Cancer Study) reported an inverse association. The combined odds ratio per 5-year increase (OR 5 ) in age at last birth and risk of endometrial cancer was 0.88 (95% CI: 0.85, 0.91), with no significant heterogeneity observed among studies (P = 0.12). When we excluded the 2 studies (California Teachers Study and Patient Epidemiologic Data System Study) with data on age at last pregnancy of any length rather than age at last birth from the pooled analysis, the combined OR 5 was unchanged (OR 5 = 0.88, 95% CI: 0.84, 0.92). Table 3 shows the results of the pooled analysis of complete individual data. The OR 5 in all women was 0.87 (95% CI: 0.85, 0.90), essentially the same as the OR 5 estimated using meta-analysis. Table 3 also shows the results of examining age at last birth categorically. Women who had their last birth at 40 years of age or older were at a 44% decreased risk of endometrial cancer (OR = 0.56, 95% CI: 0.47, 0.66) than were women who had their last child before 25 years of age. We further examined this association among women with 2 or more births both with and without adjustment for age at first birth (categorical and linear term) and also stratified by age at first birth categories; results were similar (Web Tables 1 and 2 , available at http://aje.oxfordjournals.org/).
The associations between age at last birth and risk of endometrial cancer were similar across the 4 age-at-diagnosis/reference groups (<50, 50-59, 60-69, or ≥70 years) ( Table 3) . A significant trend was observed in all age groups (P trend ≤ 0.0003). The OR 5 was 0.81 (95% CI: 0.72, 0.91) for women younger than 50 years of age, 0.87 (95% CI: 0.82, 0.91) for women aged 50-59 years, 0.88 (95% CI: 0.84, 0.92) for women aged 60-69 years, and 0.89 (95% CI: 0.83, 0.94) for women aged 70 years or older. The test for interaction between age group (at diagnosis/reference) and age at last birth was not statistically significant (P = 0.67).
We examined the race/ethnicity-specific association between age at last birth and endometrial cancer in the 3 major racial/ethnic groups: whites (6,946 cases and 14,059 controls), blacks (186 cases and 566 controls), and Asians (1,297 cases and 1,598 controls) (Web Table 3 ). An inverse association between increasing age at last birth and endometrial cancer risk was observed in whites (OR 5 = 0.87, 95% CI: 0.84, 0.89; P trend < 0.0001) and to a lesser extent in Asians (OR 5 = 0.92, 95% CI: 0.84, 1.02; P trend = 0.09). No association was observed in the small subset of black women (OR 5 = 0.98, 95% CI: 0.83, 1.16; P trend = 0.70). The P value for test for interaction between race/ethnicity and age at last birth ( per 5-year increase) was 0.025.
We also examined the association between age at last birth and endometrial cancer by study type (cohort vs. casecontrol). The associations in the cohort studies (OR 5 = 0.90, 95% CI: 0.85, 0.95; P trend < 0.0001) and in the case-control studies (OR 5 = 0.86, 95% CI: 0.83, 0.90; P trend < 0.0001) were similar. Table 4 shows the association between age at last birth and endometrial cancer by parity. A significant inverse association with increasing age at last birth was observed among women with at least 2 births (P trend < 0.0001). Among uniparous women, we observed a modest inverse a Age, study, and race/ethnicity stratified and adjusted for age at menarche, parity, body mass index, oral contraceptive use, menopausal hormone use, smoking, and diabetes.
b Study and race/ethnicity stratified and adjusted for age at menarche, parity, body mass index, oral contraceptive use, menopausal hormone use, smoking, and diabetes. association with increasing age at last birth (OR 5 = 0.92, 95% CI: 0.87, 0.98; P trend = 0.058). The test of interaction was not statistically significant across the 4 parity groups (P interaction = 0.09) or when we limited the analysis to multiparous women (P interaction = 0.30).
We also examined effect modification by BMI (Web Table 4 ) and exogenous hormone use (OC and menopausal estrogen) (Web Table 5 ). We observed no significant interaction between age at last birth and any of these hormonal exposures (P interaction ≥ 0.12).
Finally, Table 5 shows the pooled odds ratios relating age at last birth to histology-specific risks. Increasing age at last birth was associated with a reduced risk of both types of endometrial cancer: 7,643 type I tumor cases (OR 5 = 0.87, 95% CI: 0.84, 0.89; P trend < 0.0001) and 674 type II tumor cases (OR 5 = 0.90, 95% CI: 0.84, 0.97; P trend = 0.01). The P value for the difference in the OR 5 between type I and type II tumors was 0.32. Results for type I tumors were similar when we restricted the analysis to the "purest" type I tumors, that is, grade 1 endometrioid tumors (1,168 cases; OR 5 = 0.87, 95% CI: 0.81, 0.93; P trend = 0.0001).
DISCUSSION
The present pooled analysis of individual data from 17 epidemiologic studies is to our knowledge the largest investigation to date of the risk of endometrial cancer in relation to age at last birth and how tumor histology and other risk factors influence the relation. The analysis provides strong evidence that late age at last birth is independently associated with a lower risk of endometrial cancer. Risk decreases by approximately 13% per 5-year delay in last birth. Similar associations were seen for both type I and type II tumors and across all categories of age, parity, BMI, OC use, and menopausal estrogen use.
Several studies have examined the association between age at last birth or pregnancy and endometrial cancer risk (2-8, 10, 12, 21, 35-37), with the majority of studies reporting an inverse association (2-10); 5 of these published studies (the Fred Hutchinson Cancer Research Center Study, Iowa Women's Health Study, Nurses' Health Study, Polish Endometrial Cancer Study, and Shanghai Endometrial Cancer Study) (3, 12, 21, 36, 37) were included in the present pooled analysis. Seven studies have examined the association between time since last birth or pregnancy and endometrial cancer risk (2, 9, 12, 35, 36, 38, 39) , with the majority of studies reporting an increasing risk with increasing time since last birth or pregnancy (2, 9, 35, 38, 39) . In our pooled analysis, we did not include time since last birth in the statistical models because once the age at diagnosis/reference date is fixed, age at last birth and time since last birth are perfectly correlated. We have approached the issue of distinguishing between age at last birth and time since last birth by investigating the relation of age at last birth to risk of endometrial cancer within strata of age at diagnosis.
Although we found no modification of effect by most factors examined, we did not find an association between age at last birth and endometrial cancer risk in black women. It is possible that it was due to the small number of black women (186 cases and 566 controls) in our pooled analysis. The distribution of age at last birth among blacks was not strikingly different from the distributions among whites or Asians. In our study, type II tumors were more common in blacks (19%) than in whites (8%) or Asians (4%). However, we found that the association of age at last birth with type II tumors was only slightly weaker than that with type I tumors. When the analysis in blacks was restricted to type I tumors (141 cases), the odds ratio for endometrial cancer per 5-year increase in age at last birth was 0.94 (95% CI: 0.78, 1.14), slightly lower than the odds ratio for all tumors combined among black women (odds ratio = 0.98, 95% CI: 0.83, 1.16). The apparent lack of association between age at last birth and risk of endometrial cancer in blacks warrants additional study among larger groups of black women. Several potential biologic mechanisms have been suggested for why late age at last birth might protect against endometrial cancer, including: 1) women capable of becoming pregnant at an older age may possess a "healthy" endometrium or experience fewer anovulatory cycles (3, 6); 2) prolonged exposure to progesterone during pregnancy may be particularly beneficial at older ages, the critical period for endometrial cancer development (3); and 3) shedding of premalignant and malignant cells, which are more likely to exist with increasing age, from the mucosal lining of the uterine cavity during childbirth (40) . Whatever the underlying mechanism(s) is/are, our findings that the association was seen even among women aged 70 years or older at diagnosis suggest that the reduced risk associated with having a late age at last birth is long-lasting. Also, the fact that the association was similar in type I and type II tumors suggests that the impact of late age at last birth is probably estrogen-independent.
The strengths of the present study include the large sample size, which provides greater statistical power than any individual study alone, especially with regard to type II tumors and subgroup analyses; the minimal, if any, publication bias because inclusion of an individual study in our analysis was not dependent on whether results had been previously published; and the comparability across studies, in that we used individual-level data to standardize the definitions and modeling approaches for the exposure and potential confounders, which is not possible in meta-analyses based on published estimates. Nonetheless, heterogeneity in exposure assessment in how each study asked about certain exposures is a limitation of pooled analyses. In the present project, this limitation is of more concern for certain potential confounders (e.g., menopausal hormone use) than for age at last birth. Furthermore, the fact that there was no central pathologic review of tumor histology might lead to misclassification of tumor types.
In summary, the present large pooled analysis provides strong evidence that late age at last birth is associated with a reduced risk of endometrial cancer independent of other known risk factors and that this reduction in risk is longlasting. Future investigations should focus on biologic mechanisms underlying this association to further clarify endometrial carcinogenesis. Abbreviations: CI, confidence interval; OR, odds ratio. P value for the difference in odds ratio per 5-year increase between type I and type II tumors = 0.32. a Type I tumors include endometrioid, adenocarcinoma not otherwise specified, papillary adenocarcinoma, adenocarcinoma tubular, mucinous adenocarcinoma, and adenocarcinoma with squamous metaplasia.
b Type II tumors include serous, papillary serous, squamous, adenosquamous, mixed cell parts serous. c The odds ratio was calculated using polytomous logistic regression adjusted for age, race/ethnicity, study, age at menarche, parity, body mass index, oral contraceptive use, menopausal hormone use, smoking, and diabetes.
